93 related articles for article (PubMed ID: 15667610)
1. Sodium ferric gluconate for post-transplant anemia in pediatric and young adult renal transplant recipients.
Gillespie RS; Symons JM
Pediatr Transplant; 2005 Feb; 9(1):43-6. PubMed ID: 15667610
[TBL] [Abstract][Full Text] [Related]
2. Anemia control in renal transplant recipients receiving continuous erythropoietin receptor activator (C.E.R.A.) treatment: the AnemiaTrans Study.
Sánchez-Fructuoso AI; Ruiz JC; Torregrosa JV; González E; Gómez E; Gallego RJ; Troya MI; Jimenez C; Llamas F; Romero R; Bernis C; Crespo JF; Guirado L;
Adv Ther; 2012 Nov; 29(11):979-91. PubMed ID: 23160946
[TBL] [Abstract][Full Text] [Related]
3. Sodium ferric gluconate therapy in renal transplant and renal failure patients.
Yorgin PD; Belson A; Sarwal M; Alexander SR
Pediatr Nephrol; 2000 Dec; 15(3-4):171-5. PubMed ID: 11149105
[TBL] [Abstract][Full Text] [Related]
4. Anemia in pediatric renal transplant recipients.
Kausman JY; Powell HR; Jones CL
Pediatr Nephrol; 2004 May; 19(5):526-30. PubMed ID: 15007719
[TBL] [Abstract][Full Text] [Related]
5. Sodium ferric gluconate (SFG) in complex with sucrose for IV infusion: bioequivalence of a new generic product with the branded product in healthy volunteers.
Baribeault D
Curr Med Res Opin; 2011 Aug; 27(8):1653-7. PubMed ID: 21714710
[TBL] [Abstract][Full Text] [Related]
6. [Iron replacement in hemodialysis patients with a normal serum ferritin level].
Riedel MK; Morgenstern T
Dtsch Med Wochenschr; 2004 Sep; 129(36):1849-53. PubMed ID: 15368155
[TBL] [Abstract][Full Text] [Related]
7. Regular low-dose intravenous iron therapy improves response to erythropoietin in haemodialysis patients.
Taylor JE; Peat N; Porter C; Morgan AG
Nephrol Dial Transplant; 1996 Jun; 11(6):1079-83. PubMed ID: 8671972
[TBL] [Abstract][Full Text] [Related]
8. Short-term stability of a new generic sodium ferric gluconate in complex with sucrose.
Baribeault D
Curr Med Res Opin; 2011 Dec; 27(12):2241-3. PubMed ID: 21992082
[TBL] [Abstract][Full Text] [Related]
9. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of ferumoxytol versus sodium ferric gluconate in anemia management in outpatient hemodialysis patients: A prospective cohort study.
El Nekidy WS; El-Masri MM; Kadri A; Soong DC
Clin Nephrol; 2021 Apr; 95(4):189-194. PubMed ID: 33433318
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of sodium ferric gluconate complex in patients with chronic kidney disease.
Panesar A; Agarwal R
Am J Kidney Dis; 2002 Nov; 40(5):924-31. PubMed ID: 12407636
[TBL] [Abstract][Full Text] [Related]
12. Darbepoetin alfa and ferric gluconate ameliorate the anemia associated with recessive dystrophic epidermolysis bullosa.
Kuo DJ; Bruckner AL; Jeng MR
Pediatr Dermatol; 2006; 23(6):580-5. PubMed ID: 17156003
[TBL] [Abstract][Full Text] [Related]
13. Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study.
Coyne DW; Kapoian T; Suki W; Singh AK; Moran JE; Dahl NV; Rizkala AR;
J Am Soc Nephrol; 2007 Mar; 18(3):975-84. PubMed ID: 17267740
[TBL] [Abstract][Full Text] [Related]
14. Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia.
Karkouti K; McCluskey SA; Ghannam M; Salpeter MJ; Quirt I; Yau TM
Can J Anaesth; 2006 Jan; 53(1):11-9. PubMed ID: 16371604
[TBL] [Abstract][Full Text] [Related]
15. Anemia treatment with erythropoietin in pregnant renal recipients.
Cyganek A; Pietrzak B; Kociszewska-Najman B; Sanko-Resmer J; Paczek L; Wielgos M
Transplant Proc; 2011 Oct; 43(8):2970-2. PubMed ID: 21996203
[TBL] [Abstract][Full Text] [Related]
16. Intravenous iron therapy in pediatric transplant recipients: what do we really know?
Yorgin P
Pediatr Transplant; 2005 Feb; 9(1):1-3. PubMed ID: 15667602
[No Abstract] [Full Text] [Related]
17. Anemia in pediatric hemodialysis patients: results from the 2001 ESRD Clinical Performance Measures Project.
Frankenfield DL; Neu AM; Warady BA; Fivush BA; Johnson CA; Brem AS
Kidney Int; 2003 Sep; 64(3):1120-4. PubMed ID: 12911565
[TBL] [Abstract][Full Text] [Related]
18. Changing patterns of anemia management in US hemodialysis patients.
Freburger JK; Ng LJ; Bradbury BD; Kshirsagar AV; Brookhart MA
Am J Med; 2012 Sep; 125(9):906-14.e9. PubMed ID: 22938926
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human erythropoietin in renal transplant recipients with renal anemia.
Traindl O; Barnas U; Franz M; Falger S; Klauser R; Kovarik J; Graf H
Clin Transplant; 1994 Feb; 8(1):45-8. PubMed ID: 8136567
[TBL] [Abstract][Full Text] [Related]
20. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
